The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

23 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Multitarget drug discovery for tuberculosis and other infectious diseases.EBI
University of Illinois At Urbana-Champaign
Head-to-head prenyl tranferases: anti-infective drug targets.EBI
University of Illinois At Urbana-Champaign
Kinetic characterization of squalene synthase from Trypanosoma cruzi: selective inhibition by quinuclidine derivatives.EBI
Instituto De Parasitolog£A Y Biomedicina&Quot;L£Pez-Neyra
 
Synthesis and biological activity of J-104,118, a novel, potent inhibitor of squalene synthaseEBI
TBA
 
The squalestatins: potent inhibitors of squalene synthase. The role of the tricarboxylic acid moiety.EBI
TBA
Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors.EBI
Bayer Pharma
Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors.EBI
Bayer Pharma
Discovery of a new 2-aminobenzhydrol template for highly potent squalene synthase inhibitors.EBI
Daiichi Sankyo
Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus.EBI
University of Illinois At Urbana-Champaign
 
Novel Zaragozic Acids from Leptodontidium elatiusEBI
TBA
 
Novel optimised quinuclidine squalene synthase inhibitorsEBI
TBA
 
Synthesis of triphosphonate analogues of farnesyl pyrophosphate. Inhibitors of squalene synthase and protein:farnesyl transferaseEBI
TBA
 
J-104,123, a novel and orally-active inhibitor of squalene synthase: Stereoselective synthesis and cholesterol lowering effects in dogsEBI
TBA
 
Synthesis of novel monocyclic squalestatin analogues as potential inhibitors of squalene synthaseEBI
TBA
 
Semi-synthetic qualestatins: Squalene synthase inhibition and antifungal activity. The SAR of C6 and C7 modificationsEBI
TBA
Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results.EBI
University of Illinois At Urbana-Champaign
Quinuclidine derivatives as potential antiparasitics.EBI
Cardiff University
Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.EBI
Instituto Venezolano De Investigaciones CientíFicas
Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.EBI
University of Illinois At Urbana-Champaign
Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.EBI
Takeda Chemical Industries
Novel reverse-turn mimics inhibit farnesyl transferase.EBI
Cold Spring Harbor Laboratory
Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivatives.EBI
Merck Research Laboratories
The squalestatins: novel inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C1-modified analogues.EBI
Glaxo Research and Development